Skip to main content

Table 3 Two-part regression model: Incremental effects of healthcare expenditure by kidney disease status among adults accounting for relevant covariates (adjusted to 2014 dollars)

From: Trends in healthcare expenditure in United States adults with chronic kidney disease: 2002–2011

Variables

Incremental Effect

95% CI

p-value

Primary Independent Variable

 No Kidney Disease

--

--

--

 CKD only

17,472***

13,784–21,160

<0.001

 Other Kidney Diseases

5014***

4102–5926

<0.001

Covariates

 Age 18–44

--

--

--

 Age 45–64

1459***

1211–1707

<0.001

 Age 65-85

1946***

1680–2212

<0.001

 Male

--

--

--

 Female

1123***

904 – 1342

<0.001

 NH White

--

--

--

 NH Black

−530***

−809 – - 250

<0.001

 Hispanic

−1004***

−1267 – -741

<0.001

 Others

−959***

−1514 – -405

0.001

 Married

--

--

--

 Widowed/Divorced/Single

−337***

−542 – -132

0.001

 Never married

−490***

−758 – -222

<0.001

 Less than high school

--

--

--

 High school

489***

199–778

0.001

 College or more

780***

515–1054

<0.001

 Private

--

--

--

 Public insured

966***

633–1298

<0.001

 Uninsured

−3083***

−3265–-2901

<0.001

 Non-MSA (rural)

--

--

--

 MSA (urban)

347**

115–578

0.003

 Northeast

--

--

--

 Midwest

40

−351–433

0.838

 South

−412**

−779–-45

0.027

 West

−30

−485–423

0.894

 Poor

--

--

--

 Low Income

−750***

−1101–-399

<0.001

 Middle Income

−1028***

−1356–-700

<0.001

 High Income

−830***

−1174–-487

<0.001

 Comorbidities (Ref: No disease)

--

--

--

 Diabetes

2520***

2246–2794

<0.001

 Hypertension

1209***

1014–1405

<0.001

 CVD

3384***

3085–3684

<0.001

 Stroke

3053***

2553–3549

<0.001

 Emphysema

2216***

1702–2731

<0.001

 Joint pain

1168***

976–1360

<0.001

 Arthritis

1744***

1521–1966

<0.001

 Asthma

1497***

1007–1986

<0.001

 Year 2002/03

--

--

--

 Year 2004/05

476***

162–790

0.003

 Year 2006/07

467***

172–762

0.002

 Year 2008/09

293**

24–562

0.033

 Year 2010/11

658***

346–969

<0.001

  1. ** Level of significance p ≤ 0.05, ***level of significance p ≤ 0.01; MSA is metropolitan statistical area; Reference for all comorbidities is absence of disease; Primary outcome variable in this model is total health expenditures